| Aldose Reductase: A cause and a potential target for the treatment of diabetic complications S Thakur, SK Gupta, V Ali, P Singh, M Verma Archives of Pharmacal Research 44, 655-667, 2021 | 89 | 2021 |
| Drug-metabolizing enzymes: role in drug resistance in cancer G Kaur, SK Gupta, P Singh, V Ali, V Kumar, M Verma Clinical and Translational Oncology 22 (3), 1667–1680, 2020 | 86 | 2020 |
| Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: a review P Singh, V Kumar, SK Gupta, G Kumari, M Verma Medical Oncology 38, 2021 | 46 | 2021 |
| Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy SK Gupta, P Singh, V Ali, M Verma Oncology Reviews 14 (2), 2020 | 46 | 2020 |
| Transport and metabolism of tyrosine kinase inhibitors associated with chronic myeloid leukemia therapy: a review V Kumar, P Singh, SK Gupta, V Ali, M Verma Molecular and Cellular Biochemistry 477 (4), 1261-1279, 2022 | 28 | 2022 |
| Drought and Heat Tolerance in Chickpea: Transcriptome and Morphophysiological Changes Under Individual and Combined Stress R Yadav, S Juneja, P Singh, S Kumar Plant Tolerance to Individual and Concurrent Stresses, 91-109, 2017 | 8 | 2017 |
| Alterations in cellular metabolisms after Imatinib therapy: a review V Kumar, P Singh, SK Gupta, V Ali, Jyotirmayee, M Verma Medical Oncology 39 (7), 95, 2022 | 6 | 2022 |
| Novel pharmacological approach for the prevention of multidrug resistance (MDR) in a human leukemia cell line SK Gupta, P Singh, R Chhabra, M Verma Leukemia Research 109, 106641, 2021 | 6 | 2021 |
| Downregulation of Bcr-Abl oncogene in Chronic Myeloid Leukemia by microRNAs P Singh, SK Gupta, V Ali, M Verma Asian Pacific Journal of Health Sciences 5 (4), 65-84, 2018 | 4 | 2018 |
| Therapeutic approaches to enhance the BCR-ABL tyrosine kinase inhibitors efficacy in chronic myeloid leukemia SK Gupta, P Singh, V Ali, M Verma Asian Pacific Journal of Health Sciences 6, 58-69, 2019 | 3 | 2019 |
| Small in Size, Big in Impact: Marine Microbes, a Boon for Biotherapeutics P Singh, KC Saini, V Ali, SK Gupta, M Verma Marine Niche: Applications in Pharmaceutical Sciences, 73-88, 2020 | 2 | 2020 |
| MicroRNA based combinatorial therapy against TKIs resistant CML by inactivating the PI3K/Akt/mTOR pathway: a review P Singh Medical Oncology 40 (300), 2023, 2023 | 1 | 2023 |
| miR-145-5p and miR-203a-5p overcome imatinib resistance in myelogenous leukemic cells through metabolic reprogramming P Singh, S Kumar Gupta, V Ali, R Chhabra, M Verma Indian Journal of Biochemistry and Biophysics (IJBB) 60 (3), 167-176, 2023 | 1 | 2023 |
| Antileukemic Activity of hsa-miR-203a-5p by Limiting Glutathione Metabolism in Imatinib-Resistant K562 Cells P Singh, R Yadav, M Verma, R Chhabra Current issues in molecular biology 44 (12), 6428-6438, 2022 | 1 | 2022 |
| Analysis of the Inhibitory Effect of hsa-miR-145-5p and hsa-miR-203a-5p on Imatinib-Resistant K562 Cells by GC/MS Metabolomics Method P Singh, R Yadav, M Verma, R Chhabra Journal of the American Society for Mass Spectrometry, 2023 | | 2023 |
| Non-alcoholic fatty liver disease progression and current research S Narayan, SK Gupta, P Singh, V Ali, M Verma Asian Pacific Journal of Health Sciences 6 (1), 189-198, 2019 | | 2019 |
| miRNA: An Alternative Therapy for Chronic Myeloid Leukemia A Neog, P Singh, SK Gupta, M Verma Asian Pacific Journal of Health Sciences 6 (1), 162-176, 2019 | | 2019 |
| METABOLIC FLUX ANALYSIS IN PLANT METABOLIC NETWORK V Ali, P Singh, SK Gupta, VY Muley, M Verma Research Journal of Life Sciences, Bioinformatics, Pharmaceutical and …, 2019 | | 2019 |
Dr. Sonu Kumar GuptaMedical College of Georgia, Augusta University, Augusta, GA, USA在 augusta.edu 的电子邮件经过验证
